NLRP3 and Parkinson disease: MSCs and probiotic-driven improvement of PD-associated symptoms have been previously reported; however, to the best of our knowledge, the current study was the first that investigated the potential role of the NLRP3 inflammasome in the neuroprotective effects of MSCs and probiotic as well as the potential interactions between them in the PD model.